NOD-SCID mice (6–8 weeks, Female, SPF degree, 22 ± 3 g) were purchased from Beijing HFK Bioscience Co (Beijing, China). All mice were housed and maintained under specific pathogen-free (SPF) conditions as our described previously (12, 13). All procedures were approved by the Institutional Animal Care and Use Committee of Children’s Hospital of of Chongqing Medical University. A spontaneous BC metastasis mouse model was established as previously described (11). Briefly, 4T1 cells (1 × 105) in 100 µl PBS buffer were subcutaneously injected into in the left mammary fat pad of NOD-SCID mice. After 3 to 5 days, 4T1-bearing mice were randomly divided into two groups to receive 0.9% NaCl or 15 mg/kg Sax orally daily (n = 3–5 mice/group). For ALA intervention in vivo, 4T1-bearing mice were randomly divided into two groups to receive intraperitoneal (i.p.) administration of 0.9% NaCl or ALA (80 mg/kg in 0.9% NaCl) three times per week (n = 3–5 mice/group). At the end of experiments, experimental mice were sacrificed, and liver and lung tissues were harvested for the analysis of H&E and immunohistochemistry staining.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.